semaglutide patent expiry 2031 No Generics Approved in China One Month After The Heavy Price of GLP-1

After the plunger reaches the bottom, hold the needle in place for 5 to 10 seconds

Reports of severe adverse events include allergic reactions ranging from mild rashes to anaphylactic shock, kidney dysfunction particularly with high doses or prolonged use, liver toxicity in susceptible individuals, and thyroid dysfunction affecting hormone regulation

GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)along with tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, have transformed the management of type 2 diabetes and obesity

The Active Ingredient Remains the Same The FDA requires that all generic drug manufacturers use the same active ingredient in generics as the name-brand counterparts

K., Jung, D., Chung, Y., & Kang, Y